EDWARD LANE: Open Payments
NPI 1801105077 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$759 in 39 payments from 13 companies in 2025. Trend: 2023 $931 · 2024 $1,069 · 2025 $759
Food & beverage: $759
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $149 |
| PFIZER INC. | 7 | $148 |
| Novo Nordisk Inc | 5 | $96 |
| Lilly USA, LLC | 5 | $85 |
| Amgen Inc. | 4 | $72 |
| Exact Sciences Corporation | 2 | $57 |
| ABBVIE INC. | 1 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
| ANI Pharmaceuticals, Inc. | 1 | $24 |
| Bausch Health US, LLC | 1 | $19 |
Products named: PREVNAR 20, MOUNJARO, Wegovy, Cologuard Collection Kit, OTEZLA, BREZTRI, AIRSUPRA, ELIQUIS.
Industry payments across CO — which companies pay providers there.
